172@29@17@101!~!172@29@0@53!~!|news|business|ipo|thyrocare-tech-debuts-at-rs-665sh-49-premium-over-issue-price-1016748.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
you are here: HomeNewsBusinessIPO
Last Updated : May 09, 2016 05:14 PM IST | Source: Moneycontrol.com

Thyrocare Tech debuts at Rs 665/sh, 49% premium over issue price

The initial public offering (IPO) of Thyrocare was oversubscribed 73.55 times in a price band of Rs 420-446. The issue was open for bidding from April 27-29.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Thyrocare Technologies saw many takers on its first day at bourses. The diagnostics company debuted at Rs 665 per share on the NSE, 49 percent premium to its issue price at Rs 446.

The initial public offering (IPO) of Thyrocare was oversubscribed 73.55 times in a price band of Rs 420-446. The issue was open for bidding from April 27-29.

Thyrocare competes with diagnostics chains such as Dr Lal PathLabs, SRL Diagnostics, Metropolis Healthcare and Apollo Clinic.

Thyrocare Technologies conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. As of February 29, 2016, it offered 198 tests and 59 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.

First Published on May 9, 2016 10:00 am
Sections